OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Autoimmunity is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	384
GILZ regulates type I interferon release and sequesters STAT1	226
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	187
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	131
Advances in SLE classification criteria	129
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	119
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	107
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	101
Editorial Board	98
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	95
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	89
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	88
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	81
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	80
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	76
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	75
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	74
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	72
Lupus nephritis: new progress in diagnosis and treatment	71
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	69
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	69
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	65
Glycobiology of psoriasis: A review	63
Editorial Board	61
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	60

Editorial Board	59
Editorial Board	57
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	54
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	53
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	52
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	51
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	49
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	49
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	48
LAT1 enables T cell activation under inflammatory conditions	48
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	47
Antigenic mimicry – The key to autoimmunity in immune privileged organs	46
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	42
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	42
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	42
The complement system and human autoimmune diseases	40